Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. Vedanta Biosciences’ proprietary approach leverages foundational discoveries in the field of mucosal immunology to generate safe and potent treatments that restore intestinal homeostasis acting via mechanisms that are orthogonal to all existing drug classes. By modulating the microbiome with this class of drugs, we have the opportunity to treat a range of autoimmune and inflammatory diseases in potentially new ways and impact the lives of patients.
Cambridge, US
Size (employees)
49 (est)+9%
Vedanta Biosciences was founded in 2010 and is headquartered in Cambridge, US
Report incorrect company information

Vedanta Biosciences Office Locations

Vedanta Biosciences has an office in Cambridge
Cambridge, US (HQ)
19 Blackstone St
Show all (1)
Report incorrect company information

Vedanta Biosciences Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$50 m

Latest funding size

$50 m

Time since last funding

2 years ago


Vedanta Biosciences's latest funding round in June 2016 was reported to be $50 m. In total, Vedanta Biosciences has raised $50 m
Show all financial metrics
Report incorrect company information

Vedanta Biosciences Online and Social Media Presence

Embed Graph
Report incorrect company information